Fang-Chi Hsu to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Fang-Chi Hsu has written about Randomized Controlled Trials as Topic.
Connection Strength
0.165
-
Katula JA, Kritchevsky SB, Guralnik JM, Glynn NW, Pruitt L, Wallace K, Walkup MP, Hsu FC, Studenski SA, Gill TM, Groessl EJ, Wallace JM, Pahor M. Lifestyle Interventions and Independence for Elders pilot study: recruitment and baseline characteristics. J Am Geriatr Soc. 2007 May; 55(5):674-83.
Score: 0.061
-
Vaz Fragoso CA, Manini TM, Kairalla JA, Buford TW, Hsu FC, Gill TM, Kritchevsky SB, McDermott MM, Sanders JL, Cummings SR, Tranah GJ. Mitochondrial DNA variants and pulmonary function in older persons. Exp Gerontol. 2019 01; 115:96-103.
Score: 0.034
-
Williams SR, Hsu FC, Keene KL, Chen WM, Nelson S, Southerland AM, Madden EB, Coull B, Gogarten SM, Furie KL, Dzhivhuho G, Rowles JL, Mehndiratta P, Malik R, Dupuis J, Lin H, Seshadri S, Rich SS, Sale MM, Worrall BB. Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke. Neurology. 2016 Jan 26; 86(4):351-9.
Score: 0.028
-
Kader AK, Sun J, Reck BH, Newcombe PJ, Kim ST, Hsu FC, D'Agostino RB, Tao S, Zhang Z, Turner AR, Platek GT, Spraggs CF, Whittaker JC, Lane BR, Isaacs WB, Meyers DA, Bleecker ER, Torti FM, Trent JM, McConnell JD, Zheng SL, Condreay LD, Rittmaster RS, Xu J. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial. Eur Urol. 2012 Dec; 62(6):953-61.
Score: 0.022
-
Newcombe PJ, Reck BH, Sun J, Platek GT, Verzilli C, Kader AK, Kim ST, Hsu FC, Zhang Z, Zheng SL, Mooser VE, Condreay LD, Spraggs CF, Whittaker JC, Rittmaster RS, Xu J. A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk. Genet Epidemiol. 2012 Jan; 36(1):71-83.
Score: 0.021